These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2837955)
1. Novel molecules that antagonize leukotriene B4 binding to neutrophils. Lin AH; Morris J; Wishka DG; Gorman RR Ann N Y Acad Sci; 1988; 524():196-200. PubMed ID: 2837955 [TBL] [Abstract][Full Text] [Related]
2. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain. Gapinski DM; Mallett BE; Froelich LL; Jackson WT J Med Chem; 1990 Oct; 33(10):2807-13. PubMed ID: 2170648 [TBL] [Abstract][Full Text] [Related]
3. omega-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists. Labaudinière R; Hendel W; Terlain B; Cavy F; Marquis O; Dereu N J Med Chem; 1992 Nov; 35(23):4306-14. PubMed ID: 1333011 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity. Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of a series of substituted-phenylpropionic acids as a novel class of leukotriene B4 antagonists. Konno M; Sakuyama S; Nakae T; Hamanaka N; Miyamoto T; Kawasaki A Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():411-4. PubMed ID: 1847779 [No Abstract] [Full Text] [Related]
6. ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist. Kishikawa K; Matsunaga N; Maruyama T; Seo R; Toda M; Miyamoto T; Kawasaki A Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():407-10. PubMed ID: 1847777 [No Abstract] [Full Text] [Related]
7. Synthesis of structural analogues of leukotriene B4 and their receptor binding activity. Konno M; Nakae T; Sakuyama S; Nishizaki M; Odagaki Y; Nakai H; Hamanaka N Bioorg Med Chem; 1997 Aug; 5(8):1621-47. PubMed ID: 9313867 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists. Jackson WT; Boyd RJ; Froelich LL; Gapinski DM; Mallett BE; Sawyer JS J Med Chem; 1993 Jun; 36(12):1726-34. PubMed ID: 8389876 [TBL] [Abstract][Full Text] [Related]
9. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Clancy RM; Dahinden CA; Hugli TE Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105 [TBL] [Abstract][Full Text] [Related]
10. Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4. Goldman DW; Gifford LA; Young RN; Marotti T; Cheung MK; Goetzl EJ J Immunol; 1991 Apr; 146(8):2671-7. PubMed ID: 1849936 [TBL] [Abstract][Full Text] [Related]
11. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN). Jackson RH; Morrissey MM; Sills MA; Jarvis MF J Pharmacol Exp Ther; 1992 Jul; 262(1):80-9. PubMed ID: 1320692 [TBL] [Abstract][Full Text] [Related]
12. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 1. Structure-activity relationships of the benzophenone nucleus. Gapinski DM; Mallett BE; Froelich LL; Jackson WT J Med Chem; 1990 Oct; 33(10):2798-807. PubMed ID: 2170647 [TBL] [Abstract][Full Text] [Related]
13. Selective modulation by guanine nucleotides of the high affinity subset of plasma membrane receptors for leukotriene B4 on human polymorphonuclear leukocytes. Sherman JW; Goetzl EJ; Koo CH J Immunol; 1988 Jun; 140(11):3900-4. PubMed ID: 2836504 [TBL] [Abstract][Full Text] [Related]
14. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists. Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012 [TBL] [Abstract][Full Text] [Related]
15. Structure/activity relationship of leukotriene B4 and its structural analogues in chemotactic, lysosomal-enzyme release and receptor-binding assays. Soyombo O; Spur BW; Soh C; Lee TH Eur J Biochem; 1993 Nov; 218(1):59-66. PubMed ID: 8243477 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the spatial arrangement of the two acid-binding sites on the human neutrophil LTB4 receptor. Chaney MO; Froelich LL; Gapinski DM; Mallett BE; Jackson WT Receptor; 1992; 2(3):169-79. PubMed ID: 1335328 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of LTB4 binding to human neutrophils by nordihydroguaiaretic acid. Maloff BL; Fefer D; Cooke GM; Ackerman NR Agents Actions; 1987 Aug; 21(3-4):358-60. PubMed ID: 2825484 [TBL] [Abstract][Full Text] [Related]
18. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels. Powell WS; Rokach J; Khanapure SP; Manna S; Hashefi M; Gravel S; Macleod RJ; Falck JR; Bhatt RK J Pharmacol Exp Ther; 1996 Feb; 276(2):728-36. PubMed ID: 8632343 [TBL] [Abstract][Full Text] [Related]
19. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils. Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959 [TBL] [Abstract][Full Text] [Related]
20. Desensitization of the leukotriene B4 receptor by partial agonists. Kiel D; Zipkin RE; Feinmark SJ Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():403-6. PubMed ID: 1847776 [No Abstract] [Full Text] [Related] [Next] [New Search]